The Effect of Inhaled Nitric Oxide on Dyspnea and Exercise Tolerance in COPD
Clinical trial NCT03679312 · COMPLETED
Trial details
- NCT number
- NCT03679312
- Sponsor
- University of Alberta
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-04
- Primary completion
- 2023-11-20
- Enrollment
- 140
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.